We are proponents of innovation and constantly follow research in the field.

The innovative treatments and genetic tests available at our clinic shorten the treatment period, accelerate the process of improvement and healing of disorders, and are non-invasive.

The personalization of medication in psychiatry, by performing genetic tests, is a world novelty and an approach that Med Anima immediately aligned itself with, because we want to improve the lives of patients with mental disorders. Complex genetic tests are a new approach internationally and are used in several psychiatric conditions to optimize treatment.

Since 2018, Med Anima has already begun using genetic testing in clinical practice.

Finding the right treatment TAKES TIME

Despite the availability of effective treatments for many mental disorders, including mood and anxiety disorders, reaching the best treatment for mental illnesses can take weeks or even months. In these circumstances, patients may become discouraged or interrupt their treatment.

It is estimated that two-thirds of patients with depression will not respond to initial treatment, and more than one-third will become treatment-resistant.

The information obtained through the GENOMIND PROFESSIONAL PGX® genetic test helps create a personalized treatment plan to effectively address the pathology and avoid or minimize side effects. This test is performed using Real-Time PCR TaqMan technology in a CLIA-certified laboratory. The sensitivity and specificity of this test are over 99%.

The Genomind Professional Pgx® test can expedite the path to finding effective treatments

Heterogeneity in medication response observed in patients can be explained by the presence of genetic variants involved in drug absorption, distribution, metabolism, elimination, intensity of action, and intrinsic activity.

The results obtained through this genetic test assist doctors in making decisions when prescribing medications for mental disorders. Sample collection is fast, painless, and non-invasive:

🧬The test is based on a saliva sample collected very simply and painlessly, non-invasively, by your attending physician using a swab from the inside of your cheek.

Genomind analysis covers a wide range of psychiatric disorders

The genes analyzed with this test are associated with a wide range of psychotropic medications and can contribute to the selection of treatment plans for: depression, anxiety, obsessive-compulsive disorder (OCD), attention-deficit/hyperactivity disorder (ADHD), bipolar disorder, post-traumatic stress disorder (PTSD), autism, schizophrenia, chronic pain, and substance abuse.

This test optimizes treatment for:

• Patients living with depression, anxiety, OCD, ADHD, bipolar disorder, PTSD, autism, schizophrenia, chronic pain, and substance abuse
• Any patient with suboptimal treatment response: previous treatment trials, poor response, or side effects
• Patients on multiple medications
• Patients with psychiatric and medical comorbidities. Comorbidity refers to the simultaneous presence of multiple conditions in a patient. In the case of anxiety disorders, comorbidity can refer to the simultaneous presence of multiple anxiety disorders (e.g., panic disorder and social phobia) or the simultaneous presence of an anxiety disorder and another disorder (e.g., depression).
• Patients with medication adherence issues

🧬 The test is based on a saliva sample collected very simply and painlessly, non-invasively, by your attending physician using a swab from the inside of your cheek.

Genomind Genetic Test – Appointment Form

Please fill in the details below to request an appointment. A member of the Med Anima team will contact you shortly after receiving the form to work out all the details together.